Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2006

View Archived Issues

Synergy seen with AT-001 and hydroxychloroquine in rheumatoid arthritis

Sitaxsentan ameliorates effects of cardioplegic arrest and cardiopulmonary bypass

Targeting Kv1.3 channels shows promise for treating autoimmune diseases

Mistletoe extract demonstrates antiangiogenic and proapoptotic activity in preclinical studies

Cardiome Pharma advances vernakalant development in third quarter

CP-690550 improves signs and symptoms of rheumatoid arthritis

Crucell completes acquisition of SBL Vaccin

Final patient treated in EDEMA3 study of DX-88 for HAE

Phase I/II study investigates Imprime PGG with G-CSF for stem cell mobilization

Contracts issued for prepandemic influenza vaccines

Synthetic human secretin improves magnetic resonance cholangiopancreatography

Study shows lenalidomide has a role in treating relapsed/refractory multiple myeloma

Novel melanocortin agonist shows efficacy in animal models of acute renal failure

Preclinical and clinical efficacy of different antiangiogenic strategies for the management of CNV

European orphan drug status for Removab antibody in gastric cancer

Galapagos and CFFT extend cystic fibrosis alliance

Nventa advances development of HspE7 following FDA meeting

ExonHit identifies companion diagnostic to assist EHT-0202 development

Cellegy's stockholders approve asset sale to ProStrakan

Betaferon approved in Australia for earliest stages of MS

Arcoxia shows similar rates of adverse cardiovascular events to diclofenac

Apricitabine has no significant adverse effect on cardiac safety

Draximage to run neuroblastoma trials of I-131 MIBG

Recent Shionogi patent discloses novel therapeutic option for HIV infection

Novel agents for dermatological disorders disclosed in recent Pfizer patent

Recent Novartis and Sankyo patents describe new treatment options for cardiovascular diseases

Gardasil available in France

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026